nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A brief review on potential application of mesenchymal stem cell and secretome in combating mortality and morbidity in COVID-19 patients
|
Mahajan, Aditi |
|
|
44 |
1 |
p. 63-73 |
artikel |
2 |
Clinical features, laboratory findings and persistence of virus in 10 children with coronavirus disease 2019 (COVID-19)
|
Jiang, Hong |
|
|
44 |
1 |
p. 94-100 |
artikel |
3 |
Comparison of the Roche cobas 6800 SARS-CoV-2 test and the Taiwan CDC protocol for the molecular diagnosis of COVID-19
|
You, Huey-Ling |
|
|
44 |
1 |
p. 101-104 |
artikel |
4 |
3D culture models to study SARS-CoV-2 infectivity and antiviral candidates: From spheroids to bioprinting
|
de Melo, Bruna A.G. |
|
|
44 |
1 |
p. 31-42 |
artikel |
5 |
Development of multi-epitope peptide-based vaccines against SARS-CoV-2
|
Lim, Hui Xuan |
|
|
44 |
1 |
p. 18-30 |
artikel |
6 |
Editorial Board
|
|
|
|
44 |
1 |
p. ii-iii |
artikel |
7 |
Exploring algae and cyanobacteria as a promising natural source of antiviral drug against SARS-CoV-2
|
Sami, Neha |
|
|
44 |
1 |
p. 54-62 |
artikel |
8 |
Level up for culture models - How 3D cell culture models benefit SARS-CoV-2 research
|
Häfner, Sophia Julia |
|
|
44 |
1 |
p. 1-6 |
artikel |
9 |
Lopinavir/ritonavir: Repurposing an old drug for HIV infection in COVID-19 treatment
|
Magro, Paola |
|
|
44 |
1 |
p. 43-53 |
artikel |
10 |
Neutralizing monoclonal antibodies for COVID-19 treatment and prevention
|
Jaworski, Juan Pablo |
|
|
44 |
1 |
p. 7-17 |
artikel |
11 |
Phytochemicals against SARS-CoV as potential drug leads
|
Swain, Shasank Sekhar |
|
|
44 |
1 |
p. 74-85 |
artikel |
12 |
SARS-CoV-2, the other face to SARS-CoV and MERS-CoV: Future predictions
|
Abdelghany, T.M. |
|
|
44 |
1 |
p. 86-93 |
artikel |